Span Divergent Ltd (524727) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524727 | NSE: | Chemicals | Small Cap

Span Divergent Share Price

31.92 0.00 0.00%
as on 01-Dec'25 16:59

Span Divergent Ltd (524727) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524727 | NSE: | Chemicals | Small Cap

DeciZen - make an informed investing decision on Span Divergent

Based on:

M-Cap below 100cr DeciZen not available

Span Divergent stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
19.33
Market Cap:
17.4 Cr.
52-wk low:
19
52-wk high:
45.3

Is Span Divergent Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Span Divergent: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Span Divergent Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 8.7%-1%-3.6%-5.6%-0.6%0.1%-19%-9%4.3%2.7%-
Value Creation
Index
-0.4-1.1-1.3-1.4-1.0-1.0-2.4-1.6-0.7-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 02.41.71.71.71.5221.91.60
Sales YoY Gr.-NA-28.9%1.8%-1.2%-14.6%34.3%0%-2.6%-15.7%-
Adj EPS -3.5-5.1-7.5-3.9-1.1-0.1-3.1-1.11.40.91.7
YoY Gr.-NANANANANANANANA-34.5%-
BVPS (₹) 92.592.486.880.780.180.165.959.762.563.664.6
Adj Net
Profit
-1.9-2.8-4.1-2.1-0.6-0-1.7-0.60.80.51
Cash Flow from Ops. -4.1-0.92.4-1.11.10.4-0.30.60.51-
Debt/CF from Ops. 0-9.14-3.82.27.4-8.44.43.71.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-1.2%-6.4%-15.7%
Adj EPS NANANA-34.5%
BVPS-4.1%-4.5%-1.1%1.9%
Share Price -8.3% 16.8% 37.4% -10.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-3.5-5.5-8.4-4.6-1.4-0.1-4.3-1.72.31.52.6
Op. Profit
Mgn %
0-175.9-252.9-71.8-17.44.823.225.511.51.5NAN
Net Profit
Mgn %
0-116.4-242.5-121.9-35.2-2.5-87.1-30.139.731INF
Debt to
Equity
00.20.20.10.10.10.10.10.10.10.1
Working Cap
Days
01,2911,0272895327213082752902700
Cash Conv.
Cycle
0-12449339-61125510

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Span Divergent Ltd.

Standalone Consolidated
TTM EPS (₹) 1.7 -2.3
TTM Sales (₹ Cr.) 0 10.9
BVPS (₹.) 64.6 -5.8
Reserves (₹ Cr.) 30 -9
P/BV 0.49 -5.51
PE 19.33 0.00
From the Market
52 Week Low / High (₹) 19.01 / 45.30
All Time Low / High (₹) 1.20 / 101.50
Market Cap (₹ Cr.) 17.4
Equity (₹ Cr.) 5.5
Face Value (₹) 10
Industry PE 48.1

Management X-Ray of Span Divergent:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Span Divergent - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Span Divergent

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales02.391.701.731.711.461.961.961.911.61
Operating Expenses 5.256.585.982.972.011.393.201.461.691.59
Manufacturing Costs0.010.040.060.060.060.060.070.060.070.06
Material Costs01.560.070000000
Employee Cost 0.571.633.141.711.370.951.141.041.181.20
Other Costs 4.683.352.721.200.570.371.980.350.450.33
Operating Profit -5.25-4.20-4.29-1.24-0.300.07-1.230.500.220.02
Operating Profit Margin (%) --175.0%-252.0%-71.8%-17.4%4.8%-62.9%25.5%11.5%1.5%
Other Income 2.744.023.411.231.491.752.840.741.551.15
Interest 00.170.700.170.230.040000
Depreciation 0.170.340.561.120.920.650.510.420.340.25
Exceptional Items 7.420-0.64-1.83-0.54-1.11-9.17-4.110.080.06
Profit Before Tax 4.74-0.69-2.78-3.13-0.490.02-8.07-3.301.510.98
Tax 1.210.160.300.11-0.140.02-0.320.0400.14
Profit After Tax 3.53-0.84-3.08-3.24-0.35-0-7.76-3.341.510.84
PAT Margin (%) --35.4%-181.0%-187.0%-20.5%-0.1%-395.0%-170.0%78.9%52.2%
Adjusted EPS (₹)6.5-1.6-5.6-5.9-0.60.0-14.2-6.12.81.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 50.5350.4947.4144.0943.7243.7335.9732.6234.1234.75
Share Capital 5.465.465.465.465.465.465.465.465.465.46
Reserves 45.0745.0341.9538.6338.2638.2730.5127.1628.6629.29
Minority Interest0000000000
Debt08.509.804.172.422.762.562.541.981.92
Long Term Debt01.900.090.071.492.762.562.541.981.92
Short Term Debt06.609.704.100.9300000
Trade Payables0.090.130.020.090.130.200.060.060.020.05
Others Liabilities 0.360.881.621.253.143.162.202.332.253.15
Total Liabilities 50.986058.8449.6049.4149.8540.7937.5538.3639.87

Fixed Assets

Gross Block2.535.288.938.929.377.116.99776.85
Accumulated Depreciation0.410.761.011.714.532.723.083.403.683.47
Net Fixed Assets 2.124.537.917.214.854.393.913.593.313.38
CWIP 0.030.9200.010.020.020000
Investments 38.3946.1448.3940.7440.7042.8835.1031.8633.2235.15
Inventories0000000000
Trade Receivables0.1300.290.240.230.120.100.160.190.33
Cash Equivalents 1.570.410.980.450.040.130.050.250.380.42
Others Assets 8.7581.260.943.572.311.631.691.270.59
Total Assets 50.986058.8449.6049.4149.8540.7937.5538.3639.87

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -4.14-0.932.44-1.091.100.37-0.310.580.531
PBT -2.68-0.69-2.78-3.13-0.490.02-8.07-3.301.510.98
Adjustment -1.75-1.52-1.521.890.200.058.553.97-1-0.80
Changes in Working Capital -5.140.686.580.041.460.37-0.710.020.070.48
Tax Paid -1.990.590.160.11-0.06-0.06-0.07-0.11-0.050.34
Cash Flow From Investing Activity 10.26-8.56-2.526.390.47-0.570.43-0.360.16-1.10
Capex -1.92-5-2.200.030.102.010.97-0.010.90-0.30
Net Investments 7.97-4.80-1.425.61-0.22-3.18-1.13-0.87-1.30-1.32
Others 4.211.241.090.760.590.590.590.520.560.53
Cash Flow From Financing Activity -12.168.330.67-5.82-1.970.30-0.20-0.02-0.560.15
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00000000-0.56-0.06
Interest Paid 0-0.17-0.70-0.17-0.22-0.040000
Dividend Paid 00-0.01-0.020-0.010000
Others -12.168.501.39-5.63-1.750.34-0.20-0.0200.20
Net Cash Flow -6.04-1.160.59-0.52-0.410.10-0.080.200.130.04

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)6.46-1.67-6.29-7.09-0.80-19.47-9.734.522.44
ROCE (%)8.68-0.95-3.57-5.62-0.550.13-18.99-8.954.252.69
Asset Turnover Ratio00.040.030.030.030.030.040.050.050.04
PAT to CFO Conversion(x)-1.17N/AN/AN/AN/AN/AN/AN/A0.351.19
Working Capital Days
Receivable Days006256504421253459
Inventory Days0000000000
Payable Days0253870000000

Span Divergent Ltd Stock News

Span Divergent Ltd FAQs

The current trading price of Span Divergent on 01-Dec-2025 16:59 is ₹31.92.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Nov-2025 the market cap of Span Divergent stood at ₹17.43.
The latest P/E ratio of Span Divergent as of 30-Nov-2025 is 19.33.
The latest P/B ratio of Span Divergent as of 30-Nov-2025 is 0.49.
The 52-week high of Span Divergent is ₹45.30 and the 52-week low is ₹19.01.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Span Divergent is ₹0.00 ( Cr.) .

About Span Divergent Ltd

A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant vigil. 

The initial efforts yielded success and SPAN became a private limited company in 1981.The company went public in 1994,to bring in more resources and expand further Concurrently , Span Diagnostics Ltd. with a strengthened marketing & distribution network, emerged as a leader in Indian diagnostic market. 

Today, SPAN – a legendary name in the industry is reckoned for its wide range of quality products and dedicated services. The company operates through strategic marketing divisions, ensuring focused approach to specific customer segments. 

Span Diagnostics Ltd. is a pioneer and trend setter of high quality products for pathology & clinical laboratories in the Indian diagnostics industry. A globally acknowledged and fastest growing diagnostic company with a successful track record of over 3 decades having Asia's one of the largest state-of-the-art ISO-9001:2000, WHO cGMP accredited advanced manufacturing facilities with ISO 13485 & CE accredited products. We have our marketing activities across India and 68 countries worldwide. SPAN services end users and distributors with ready to use testing kits and customized OEM products.

SPAN has nurtured its growth by consistently adding new products through R & D endeavors. The products are manufactured at its state-of-the-art plants in India and France , observing WHO-   cGMP norms. 

SPAN also takes pride in having exclusive strategic business alliances with the leading diagnostic companies from world over, to market their products in India. 

Product range of the company includes
  • Diagnostic Reagents & Kits
  • Instruments
  • Industrial & Research Products
  • Veterinary Products
Milestones:
  • 2006 :  Started marketing and distribution office in UAE 
  •            Accredited for ISO 13485 : 2003 
  • 2005 :  Established manufacturing and R&D facility in France 
  • 2004 :  CE Registration 
  •             Started Amesos:Critical Care Product Division 
  •             Introduced IBD:Institutional Business Division. 
  • 2003:  Accredited for ISO 9001:2000 
  •            Formed iD-Serve:Technical support Division for lab automation 
  • 2002 :  Launched Cogent : Clinical Chemistry Division. 
  • 2001 : Initiated international marketing. 
  • 2000 :  Accredited for ISO 9002 and WHO cGMP. 
  •             Formed Strategic marketing Divisions 
  •             PDP : Popular Diagnostic Product Division. 
  •             Stimulus : Speciality Diagnostic Division. 
  •  1998 : Started SPAN iD : Independent Lab Automation Division. 
  •  1994 : Listed at stock exchange. 
  •  1992 : Commissioned modern manufacturing facility. 
  •  1991 : Ventured into lab automation. 
  •  1988 : Established distribution network. 
  •  1982 : Expanded manufacturing facility 
  •  1980 :  Reorganised as Span Diagnostics Pvt. Ltd. 
  •  1976 :  Foundation - Span Diagnostics . 
  •  1972 :  The beginning - Desai Laboratories. 
Achievements/ recognition:
  • ISO 13485:2003 
  • ISO 9001:2000

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×